Report cover image

U.S. Next-generation Sequencing Library Preparation Market

Published Jul 02, 2025
Length 100 Pages
SKU # GV20303405

Description

U.S. Next-generation Sequencing Library Preparation Market Summary

The U.S. next-generation sequencing library preparation market size was estimated at USD 652.2 million in 2024 and is projected to reach USD 1.96 billion by 2033, growing at a CAGR of 13.09% from 2025 to 2033. Rapid advancements in sequencing technologies and bioinformatics have facilitated the detection of DNA variations.

Additionally, the broad adoption of Next-Generation Sequencing (NGS) and Whole-Genome Sequencing (WGS) allows for the simultaneous analysis of numerous genes on a single platform, enhancing the role of DNA sequencing in clinical diagnostics. These developments are anticipated to significantly propel market growth over the forecast period.

U.S. Next-generation Sequencing Library Preparation Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. next-generation sequencing library preparation market report based on sequencing type, product, application, end use, and region:
  • Sequencing Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Targeted Genome Sequencing
  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Other Sequencing Types
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Reagents & Consumables
  • DNA Library Preparation Kits
  • RNA Library Preparation Kits
  • Other Reagents & Consumables
  • Instruments
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug & Biomarker Discovery
  • Disease Diagnostics
  • Cancer Diagnostics
  • Reproductive Health Diagnostics
  • Infectious Disease Diagnostics
  • Other Disease Diagnostic Applications
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
  • Others
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

100 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Sequencing Type Segment
1.2.2. Product Segment
1.2.3. Application Segment
1.2.4. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segmental Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, and Scope
3.1. Market Lineage
3.1.1. Parent Market Analysis
3.1.2. Ancillary Market Analysis
3.2. U.S. Next-generation Sequencing Library Preparation Market - Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Market Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.3.3. COVID-19 Impact Analysis
Chapter 4. U.S. Next-generation Sequencing Library Preparation Market: Sequencing Type Business Analysis
4.1. Sequencing Type Segment Dashboard
4.2. U.S. Next-generation Sequencing Library Preparation Market Sequencing Type Movement Analysis, 2024 & 2033
4.3. U.S. Next-generation Sequencing Library Preparation Market Size & Trend Analysis, by Sequencing Type, 2021 to 2033 (USD Million)
4.4. Targeted Genome Sequencing
4.4.1. Targeted Genome Sequencing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
4.5. Whole Genome Sequencing
4.5.1. Whole Genome Sequencing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
4.6. Whole Exome Sequencing
4.6.1. Whole Exome Sequencing Market Estimates And Forecasts, 2021 - 2033 (USD Million)
4.7. Other Sequencing Types
4.7.1. Other Sequencing Types Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Chapter 5. U.S. Next-generation Sequencing Library Preparation Market: Product Business Analysis
5.1. Product Segment Dashboard
5.2. U.S. Next-generation Sequencing Library Preparation Market Product Movement Analysis, 2024 & 2033
5.3. U.S. Next-generation Sequencing Library Preparation Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
5.4. Reagents & Consumables
5.4.1. Reagents & Consumables Market Estimates And Forecasts, 2021 - 2033 (USD Million)
5.4.2. DNA Library Preparation Kits
5.4.2.1. DNA Library Preparation Kits Market Estimates And Forecasts, 2021 - 2033 (USD Million)
5.4.3. RNA Library Preparation Kits
5.4.3.1. RNA Library Preparation Kits Market Estimates And Forecasts, 2021 - 2033 (USD Million)
5.4.4. Other Reagents & Consumables
5.4.4.1. Other Reagents & Consumables Market Estimates And Forecasts, 2021 - 2033 (USD Million)
5.5. Instruments
5.5.1. Instruments Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Chapter 6. U.S. Next-generation Sequencing Library Preparation Market: Application Business Analysis
6.1. Application Segment Dashboard
6.2. U.S. Next-generation Sequencing Library Preparation Market Application Movement Analysis, 2024 & 2033
6.3. U.S. Next-generation Sequencing Library Preparation Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Drug & Biomarker Discovery
6.4.1. Drug & Biomarker Discovery Market Estimates And Forecasts, 2021 - 2033 (USD Million)
6.5. Disease Diagnostics
6.5.1. Disease Diagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
6.5.2. Cancer Diagnostics
6.5.2.1. Cancer Diagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
6.5.3. Reproductive Health Diagnostics
6.5.3.1. Reproductive Health Diagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
6.5.4. Infectious Disease Diagnostics
6.5.4.1. Infectious Disease Diagnostics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
6.5.5. Other Disease Diagnostic Applications
6.5.5.1. Other Disease Diagnostic Applications Market Estimates And Forecasts, 2021 - 2033 (USD Million)
6.6. Others
6.6.1. Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Chapter 7. U.S. Next-generation Sequencing Library Preparation Market: End Use Business Analysis
7.1. End Use Segment Dashboard
7.2. U.S. Next-generation Sequencing Library Preparation Market End Use Movement Analysis, 2024 & 2033
7.3. U.S. Next-generation Sequencing Library Preparation Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Hospitals and Clinics
7.4.1. Hospitals and Clinics Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.5. Academic and Research Institutions
7.5.1. Academic and Research Institutions Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.6. Pharmaceutical and Biotechnology Companies
7.6.1. Pharmaceutical and Biotechnology Companies Market Estimates And Forecasts, 2021 - 2033 (USD Million)
7.7. Others
7.7.1. Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Illumina, Inc.
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Agilent Technologies, Inc.
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. F. Hoffmann-La Roche AG, Inc.
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. BD
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Oxford Nanopore Technologies
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. New England Biolabs Inc.
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Revvity, Inc.
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. QIAGEN N.V.
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Pacific Biosciences of California, Inc.
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Thermo Fisher Scientific Inc.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.